We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KB icon
2776
KB Financial Group
KB
$43.5B
$8K ﹤0.01%
218
-1,714
-89% -$61.6K
LCTX icon
2777
Lineage Cell Therapeutics
LCTX
$278M
$8K ﹤0.01%
+2,473
New +$7.59K
MG icon
2778
Mistras Group
MG
$512M
$8K ﹤0.01%
310
-390
-56% -$8.89K
MSTR icon
2779
Strategy Inc
MSTR
$38.4B
$8K ﹤0.01%
+420
New +$7.94K
NAII icon
2780
Natural Alternatives International
NAII
$14.9M
$8K ﹤0.01%
724
+65
+10% +$814
NBR icon
2781
Nabors Industries
NBR
$1.21B
$8K ﹤0.01%
9
-528
-98% -$372K
OSK icon
2782
Oshkosh
OSK
$9.59B
$8K ﹤0.01%
131
-2,510
-95% -$155K
OSPN icon
2783
OneSpan
OSPN
$618M
$8K ﹤0.01%
579
-2,230
-79% -$33.5K
PODD icon
2784
Insulet
PODD
$9.79B
$8K ﹤0.01%
221
+118
+115% +$4.4K
QAT icon
2785
iShares MSCI Qatar ETF
QAT
$64M
$8K ﹤0.01%
400
-123
-24% -$2.29K
REFR icon
2786
Research Frontiers
REFR
$17M
$8K ﹤0.01%
4,230
+4,079
+2,701% +$8.44K
SAP icon
2787
SAP
SAP
$238B
$8K ﹤0.01%
92
-755
-89% -$64.8K
SIMO icon
2788
Silicon Motion
SIMO
$8.68B
$8K ﹤0.01%
+202
New +$9.22K
TCBK icon
2789
TriCo Bancshares
TCBK
$1.83B
$8K ﹤0.01%
232
+230
+11,500% +$6.83K
TEAM icon
2790
Atlassian
TEAM
$37.8B
$8K ﹤0.01%
318
+150
+89% +$4.05K
TTGT icon
2791
TechTarget
TTGT
$278M
$8K ﹤0.01%
937
-6,571
-88% -$54.9K
VC icon
2792
Visteon
VC
$2.78B
$8K ﹤0.01%
100
-638
-86% -$47.9K
VICR icon
2793
Vicor
VICR
$10.2B
$8K ﹤0.01%
555
+551
+13,775% +$7.61K
VIRT icon
2794
Virtu Financial
VIRT
$4.93B
$8K ﹤0.01%
500
+300
+150% +$4.28K
YORW icon
2795
York Water
YORW
$514M
$8K ﹤0.01%
210
+106
+102% +$3.59K
ZD icon
2796
Ziff Davis
ZD
$1.98B
$8K ﹤0.01%
112
-852
-88% -$54.2K
LUMO
2797
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$8K ﹤0.01%
+81
New +$9.13K
HOLI
2798
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$8K ﹤0.01%
452
-699
-61% -$13.9K
TAST
2799
DELISTED
Carrols Restaurant Group, Inc.
TAST
$8K ﹤0.01%
+544
New +$7.17K
AGRX
2800
DELISTED
Agile Therapeutics
AGRX
$8K ﹤0.01%
+1
New +$14K
110 111
112
113 114

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.